O4, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that ...

On December 23, CNBC reported that Julie Biel, Chief Market Strategist at Kayne Anderson Rudnick, joined Fast Money to ...

Major U.S. stock indexes have recently pulled back after setting fresh all-time highs, reflecting a complex economic landscape influenced by geopolitical events and fluctuating oil prices. In this ...

Last week was mixed for the penny stocks and higher-priced ones alike. While there were plenty of trends to follow, some continued gaining steam heading into the middle of November. Sure, you’ve got ...

Rani Therapeutics Holdings (RANI), a clinical-stage penny biotech stock, soared nearly 250% on Friday and continued to trade higher in pre-market trading on Monday following last week’s sharp rally.

The United Kingdom's stock market has been experiencing fluctuations, with the FTSE 100 index recently closing lower due to weak trade data from China, highlighting ongoing global economic challenges.

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best biotech penny stocks to buy according to analysts. On December ...

Penny stocks can soar in price, but dabbling in them is a dangerous game. Here's a breakdown of the risks and rewards.

In this article, we take a closer look at 5 penny stocks gaining ground after releasing big news today. Thanks to even more stock market uncertainty, retail traders have turned attention to daily ...

The Fed is projected to cut interest rates again on Wednesday. On top of that, the earnings outlook for 2026 remains very strong. This backdrop should leave investors feeling bullish in December and ...